Mr. TO Simon
- Chairman of HUTCHMED
Mr. Simon To is the Executive Director and Chairman of HUTCHMED (China) Limited. He is also the managing director of Hutchison Whampoa (China) Limited.
HUTCHMED is a Hong Kong-headquartered innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It has about 5,000 personnel across all its companies, at the center of which is a team of about 1,800 in oncology/immunology. Since inception HUTCHMED has been focused on bringing cancer drug candidates from in-house discovery to patients around the world, with its first three oncology drugs now approved and marketed in China.
Mr To’s career in China spans more than 45 years. He originally established the China healthcare business of Hutchison Whampoa Limited in 2000 (now a subsidiary of CK Hutchison Holdings Limited) and has been instrumental in its acquisitions made to date. He received a Bachelor’s degree in Mechanical Engineering from Imperial College, London and a Master in Business Administration from Stanford University’s Graduate School of Business.